SUMMARY The histology of 51 cases of testicular teratoma, with or without seminoma, was reviewed and classified according to the World Health Organisation criteria. Full pathological and clinical details were obtained, and patients were followed up for periods varying from one to 10 years from orchidectomy. Multiple factors were studied in order to discover which affected prognosis. The pathological stage of the tumour proved to be the most important indicator. The previously described poor prognosis associated with yolk sac tumour was not confirmed.
Testicular teratomas traditionally carry a poor prognosis. As long ago as 1763 it was known that orchidectomy alone could produce an occasional cure,' but when the results of-treatment were first examined in detail in 19062 it was found that few people were completely cured by surgery, with less than 15% of patients surviving five years. Pugh, whose calculations were based on 553 patients with teratoma between 1958 and 1967, found a five year corrected survival rate of 45%3a. The incidence of this uncommon tumour has gradually increased over the past few decades, the highest rate (four to five per 100 000) occurring in northern Europe and in Maoris in New Zealand. With the rise in incidence have come advances in staging procedures, the development of specific tumour markers, and effective chemotherapy. In this study we focused on the pathological and clinical factors present at the time of diagnosis to discover those which indicate a poor prognosis.
Material and methods

PATIENTS
All cases diagnosed as testicular teratoma, with or without seminoma, in the histopathology department of the Belfast City Hospital between.January 1974 and April 1983 were reviewed. Clinical and follow up information were obtained from the hospital records for periods varying from one to 10 years. Two patients had to be eliminated from the study because of inadequate follow up (43) were of more than one histological type, the commonest combinations being teratocarcinoma with yolk sac and embryonal carcinoma with yolk sac. The remainder consisted of four pure embryonal carcinomas, three teratomas, and one pure yolk sac tumour. The overall median survival time was 33-7 months. The results are summarised in Table 1 .
Only four tumours were classified as teratoma (TD), and one of these also contained seminoma. Three patients are still living after 13, 48, and 119 months, but the other died seven months after orchidectomy. The numbers in this group were too small for statistical analysis.
Only five tumours contained choriocarcinoma, and in these a frequent close association with yolk sac tumour was seen; both being types of extraembryonic differentiation. Only one patient is still liv- In pathological stage one (P1) the tumour is confined to the rete and body of testis, in the second stage (P2) it has spread into the epididymis and lower cord, and in P3 it extends to the upper cord. Table 2 shows that the difference in survival between those classified as P1 and those as P2 and P3 is highly significant. Furthermore, the differences in survival of the two groups persisted when stratified for each of several other factors, including metastases at presentation, embryonal carcinoma, and duration of symptoms.
WEIGHT OF ORCHIDECTOMY SPECIMEN
The normal testis weighs between 10-5 g and 14 g. Orchidectomy specimens consisted of testis and cord and ranged from 25 g to 880 g (mean 182 g). Information was available in 48 cases (Table 2) .
METASTASES AT PRESENTATION
Information about metastases at presentation was available in 49 patients. Secondary spread was most Of the four other histological subtypes, embryonal carcinoma was the only one which was associated statistically with poor survival (p = 0.04).
Those with choriocarcinoma had a high mortality, but unfortunately the numbers were too small for statistical analysis.
Yolk sac elements were present in 72% of tumours in this series. This varied from a single microscopic focus in several cases to one pure yolk sac tumour. The median survival time of patients with yolk sac elements was much lower than those without (Table 1 ), but the difference was not statistically significant. Other researchers into germ cell tumours have had different results. Talerman,s in both retrospective and prospective studies, agreed that yolk sac elements were relatively common in adult testicular germ cell neoplasms (which explained the frequent increase in a-fetoprotein concentration), but found that the prognosis for adults with testicuAlderdice, Merrett lar tumours containing yolk sac elements was unfavourable. A study by Parkinson and Beilby6 two years later found that pure yolk sac tumours proved highly malignant and that in mixed germ cell tumours the malignant nature of the yolk sac component was maintained even when combined with somatic elements; but when seminoma was also present the survival rate improved significantly. This series showed no significant difference in-median survival time between those with yolk sac elements and those without ( Table 1 ). The one patient with a pure yolk sac tumour was alive and well at the end of follow up, 19 months after orchidectomy. This series also differed from that of Parkinson and (Fig. 1) . Unfortunately, the serum concentration of a-fetoprotein was recorded in only 59% of cases and, as small numbers lower the sensitivity of statistical analysis, the nonsignificant p value for this factor must be interpreted with caution.
,3-human chorionic gonadotrophin is not as specific a marker as a-fetoprotein. It is secreted by syncytiotrophoblastic giant cells, which may be found in seminoma and all histological subtypes of teratoma including choriocarcinoma (Fig. 2) . The immunoperoxidase technique for showing ,3-human chorionic gonadotrophin is useful for drawing attention to possible areas of choriocarcinoma, but it is not specific for it because cytotrophoblast must also be present for the diagnosis to be made (Fig. 3) . Considerably increased concentrations are, however, generally confined to cases of choriocarcinoma. The serum concentration of /8-human chorionic gonadotrophin was recorded in only 57% of cases, and, although raised concentrations of this marker had a greater effect on survival than raised serum a-fetoprotein, it did not reach statistical significance, once again because of small subgroups.
